Treatment of severe psoriasis in children: recommendations of an Italian expert group
Anna Belloni Fortina(University of Padua), Alberto Villani(University of Milan), Annalisa Patrizi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Federico Bardazzi(University of Bologna), Vito Di Lernia(Ospedale Santa Maria), Gaia Moretta(Università Cattolica del Sacro Cuore), Claudia Carnevale(Bambino Gesù Children's Hospital), Carlo Mazzatenta(Azienda Usl Toscana Centro), Ketty Peris(Agostino Gemelli University Polyclinic), Viviana Lora(Foundation Center), Carlo Gelmetti(University of Milan), Samantha Berti(University of Florence), Mirella Milioto(Azienda di Rilievo Nazionale ed Alta Specializzazione), Maya El Hachem(Bambino Gesù Children's Hospital), Iria Neri(Azienda USL di Bologna)
Cited by 80
Related Papers
Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study
|Journal of Investigative Dermatology|2005|644
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
|British Journal of Dermatology|2020|590
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
|European Journal of Cancer|2016|579